Monthly ibandronate versus weekly risedronate treatment for low bone mineral density in stable renal transplant patients

被引:9
|
作者
Sanchez-Escuredo, Ana [1 ]
Fuster, David [2 ]
Rubello, Domenico [4 ]
Muxi, Africa [2 ]
Ramos, Ana [3 ]
Campos, Francisco [2 ]
Marzola, Maria Cristina [4 ]
Cook, Gary J. [5 ]
Tapias, Andres [2 ]
Torregrosa, Jose-Vicente [1 ]
机构
[1] Hosp Clin Barcelona, Dept Nephrol & Renal Transplant, Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Nucl Med, Barcelona, Spain
[3] Fdn Jimenez Diaz, Dept Nephrol, E-28040 Madrid, Spain
[4] Santa Maria Della Misericordia Hosp, Dept Nucl Med, I-45100 Rovigo, Italy
[5] Kings Coll London, Div Imaging Sci & Biomed Engn, Dept Canc Imaging, London, England
关键词
biphosphonates; bone mineral density; ibandronate; renal transplant; risedronate; BISPHOSPHONATES; OSTEOPOROSIS;
D O I
10.1097/MNM.0000000000000316
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
IntroductionBisphosphonates may aid in treating and preventing bone loss promoted by chronic immunosuppressive treatment and secondary hyperparathyroidism in renal transplant (RT) patients. However, the effectiveness of bisphosphonates is compromised by poor patient compliance. The objective of the study was to compare the effects of once monthly ibandronate with those of weekly risedronate administration on bone mineral density (BMD) and renal function in RT patients.Patients and methodsSixty-nine patients were prospectively recruited who were at least 12 months post-RT and were treated with either oral ibandronate 150mg monthly (n=35) or oral risedronate 35mg weekly (n=34). At baseline and 1 year, creatinine, calcium, alkaline phosphatase, and i-parathyroid hormone were measured, and BMD was determined by dual-energy X-ray absorptiometry.ResultsGroup I consisted of 35 patients (28 women) treated with ibandronate who were of a mean age of 6312 years. Group II consisted of 34 patients (30 women) treated with risedronate who were of a mean age of 64 +/- 10 years. Lumbar BMD was as follows: baseline T-score (group I vs. group II) of -1.7 +/- 0.8 versus -1.9 +/- 0.8 (P=NS); and annual T-score of -1.3 +/- 0.6 versus -1.4 +/- 0.8 (P=NS). After 1 year, lumbar BMD improved to reveal a T-score of -1.3 +/- 0.6 in the ibandronate group (P<0.01) and -1.4 +/- 0.8 in the risedronate group (P<0.01). Femoral BMD was as follows: baseline T-score (group I vs. group II) of -2.1 +/- 0.7 versus -2.2 +/- 0.6 (P=NS); and annual T-score of -1.8 +/- 0.9 versus -1.8 +/- 0.8 (P=NS). Cortical bone also improved in both groups, but results were not statistically significant. No changes in renal function and no adverse effects were observed.ConclusionIn RT patients with low BMD, no difference in effects on BMD, renal function, or adverse effects were observed between monthly oral ibandronate and weekly oral risedronate administration.
引用
收藏
页码:815 / 818
页数:4
相关论文
共 50 条
  • [31] Treatment of reduced bone density with ibandronate in dialysis patients
    Bergner, Raoul
    Henrich, Dirk
    Hoffmann, Martin
    Schmidt-Gayk, Heinrich
    Lenz, Tomas
    Uppenkamp, Michael
    JOURNAL OF NEPHROLOGY, 2008, 21 (04) : 510 - 516
  • [32] BONE-MINERAL DENSITY PROFILE IN UREMIC AND RENAL-TRANSPLANT PATIENTS
    CHAO, SH
    TSAI, KS
    CHIENG, PU
    LEE, PH
    LEE, CJ
    LEE, CS
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (04) : 2009 - 2011
  • [33] Bone mineral density in pediatric and adolescent renal transplant patients:: How to evaluate
    Göksen, D
    Darcan, S
    Kara, P
    Mir, S
    Çoker, M
    Kabasakal, C
    PEDIATRIC TRANSPLANTATION, 2005, 9 (04) : 464 - 469
  • [34] Calcimimetics and Bone Mineral Density in Renal Transplant Patients With Persistent Secondary Hyperparathyroidism
    Toro Prieto, F. J.
    Bernal Blanco, G.
    Navarro Garcia, M.
    Cabello Chaves, V.
    Garcia Jimenez, R.
    Pereira Palomo, P.
    Gentil Govantes, M. A.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2144 - 2147
  • [35] Determinants of Bone Mineral Density in Stable Renal Transplant Recipients: Not Always What You Expect
    Gupta, Alok K.
    Huang, Michael
    Wong, Steven C. W.
    Prasad, G. V. Ramesh
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 67 - 68
  • [36] Efficacy of risedronate with cholecalciferol on bone mineral density in Korean patients with osteoporosis
    Park, So Young
    Kang, Moo-Il
    Park, Hyung Moo
    Rhee, Yumie
    Moon, Seong Hwan
    Yoon, Hyun Koo
    Koh, Jung-Min
    Chang, Jae Suk
    Kim, In Joo
    Won, Ye Yeon
    Park, Ye Soo
    Choi, Hoon
    Shin, Chan Soo
    Yoon, Taek Rim
    Yun, Sung-Cheol
    Chung, Ho-Yeon
    ARCHIVES OF OSTEOPOROSIS, 2019, 15 (01)
  • [37] Efficacy of risedronate with cholecalciferol on bone mineral density in Korean patients with osteoporosis
    So Young Park
    Moo-Il Kang
    Hyung Moo Park
    Yumie Rhee
    Seong Hwan Moon
    Hyun Koo Yoon
    Jung-Min Koh
    Jae Suk Chang
    In Joo Kim
    Ye Yeon Won
    Ye Soo Park
    Hoon Choi
    Chan Soo Shin
    Taek Rim Yoon
    Sung-Cheol Yun
    Ho-Yeon Chung
    Archives of Osteoporosis, 2020, 15
  • [38] Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate
    Brown, J. P.
    Roux, C.
    Ho, P. R.
    Bolognese, M. A.
    Hall, J.
    Bone, H. G.
    Bonnick, S.
    van den Bergh, J. P.
    Ferreira, I.
    Dakin, P.
    Wagman, R. B.
    Recknor, C.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (07) : 1953 - 1961
  • [39] Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate
    J. P. Brown
    C. Roux
    P. R. Ho
    M. A. Bolognese
    J. Hall
    H. G. Bone
    S. Bonnick
    J. P. van den Bergh
    I. Ferreira
    P. Dakin
    R. B. Wagman
    C. Recknor
    Osteoporosis International, 2014, 25 : 1953 - 1961
  • [40] Determinants of bone mineral density in stable kidney transplant recipients
    Gupta, Alok K.
    Huang, Michael
    Prasad, G. V. Ramesh
    JOURNAL OF NEPHROLOGY, 2012, 25 (03) : 373 - 383